Search
for
Sort by
Research 661–690 of 912
- BRCA2 in abscission
- Female androgenetic alopecia: a review.
- Simultaneous Versus Delayed Initiation of Spironolactone and Low‐Dose Oral Minoxidil: Adverse Event Rates in a Retrospective Cohort Study
- Pain in the heart, hair, on the head: Pericarditis as an unanticipated risk of low-dose oral minoxidil
- Alopecia areata: Emerging therapies and up-to-date management strategies
- Disconnect Between Patient and Dermatologist Perceptions in Androgenetic Alopecia Therapy: Social Analysis Across More Than 100,000 Digital Conversations
- Increased Efficacy of Daytime Low-dose Oral Minoxidil Dosing for Androgenetic Alopecia: A Retrospective Study
- Glucagon-Like Peptide-1 Receptor Agonists and Hair Loss: Current Evidence and Potential Mechanisms
- Clinical response and time to improvement with 308-nm excimer laser therapy in scarring alopecia: a retrospective cohort study
- Revisiting Diffuse Unpatterned Alopecia: Reappraisal of a Controversial Diagnosis
- Dupilumab and ritlecitinib combination therapy in a patient with alopecia totalis and atopic disease
- Efficacy of Topical Tretinoin and Topical Minoxidil Cotherapy in Androgenetic Alopecia: A Review
- Supplemental Materials for "No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study"
- Supplemental Materials for "No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study"
- No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study
- Supplemental Materials for "No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study"
- Platelet‐Rich Plasma Injections and Scalp Cutaneous Malignancies: Clinical Implications and Knowledge Gaps
- Time to Maximal Response with Low-Dose Oral Minoxidil in Clinical Treatment of Androgenetic Alopecia
- Supplemental Figure 1 for "Time to Maximal Response with Low-Dose Oral Minoxidil in Clinical Treatment of Androgenetic Alopecia"
- Supplemental Figure 1 for "Time to Maximal Response with Low-Dose Oral Minoxidil in Clinical Treatment of Androgenetic Alopecia"
- Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments
- 75995 Social Listening Analysis of 143,000 Online Conversations on Hair Loss Treatments: Side Effects, Satisfaction, and Discontinuation
- Topical Tacrolimus, Clobetasol, and Minoxidil (TCM) for Primary Cicatricial Alopecias: A Retrospective Analysis of Clinical Outcomes and Safety
- Alopecia in Female Athletes Using Androgenic and Anabolic Steroids: Pathophysiology and Management
- 0618 Constructing a single-cell epigenetic map of hair follicle waxing and waning in alopecia areata
- 0503 Real-world effectiveness of oral minoxidil for androgenetic alopecia over time: Plateau of benefit after 6 months
- 0519 Social media claims and tolerability of topical tretinoin plus topical minoxidil for androgenetic alopecia
- 0515 The effect of topical tretinoin use on topical minoxidil efficacy in androgenetic alopecia: A clinical review
- Single-handed vampire facial: Combining microneedling with platelet-rich plasma for single-hand use
- Dissecting cellulitis of the scalp successfully treated with infliximab